To address its serious drug use problems, Myanmar should change its drug policy towards a harm reduction approach. Instead of a repressive approach, voluntary and evidence-based treatment and public health services, including harm reduction, should be made available and become generally accepted by enforcement officials and by the community at large.
La matriz prohibicionista impuesta por el sistema internacional de fiscalización de drogas sobre el cannabis aún perdura en casi todos los países de América Latina y el Caribe. Dejar acotada la reforma únicamente al cannabis medicinal resulta ser una solución parcial, insuficiente y momentánea.
El proceso de la UNGASS 2016 en su conjunto ha ayudado a generar las condiciones necesarias para que se produzcan cambios más sustanciales en el futuro, con miras al próximo examen de alto nivel en 2019.
A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.
Cannabis use has never posed major problems in Indonesia, yet prohibitionist policies prevail. Despite the high prevalence of cannabis use, local or national discussions on cannabis policies are nearly non-existent, exacerbated by strong anti-drug views and public institutions' failure to design and implement comprehensive policies based on evidence.